WASHINGTON, Nov. 9, 2023
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)
today announced that the company will participate in the following
upcoming investor conferences in November
2023:
The Stifel 2023 Healthcare Conference on Tuesday, November 14, 2023. A corporate
presentation is scheduled for 4:10 p.m.
Eastern Time.
The Jefferies 2023 London Healthcare Conference on Thursday, November 16, 2023. A corporate
presentation is scheduled for 2:00
p.m. Greenwich Mean Time (9:00 a.m.
Eastern Time).
The corporate presentations given at the Stifel and Jefferies
conferences may be accessed live on Vanda's corporate website,
www.vandapharma.com. Investors should click on the Investors tab
and follow the links under Recent Events. Investors are advised to
go to the conference websites at least 15 minutes early to
register, download, and install any necessary software or
presentations. Links to the archived conferences will be available
on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading
global biopharmaceutical company focused on the development and
commercialization of innovative therapies to address high unmet
medical needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com and
follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2023-investor-conferences-301983975.html
SOURCE Vanda Pharmaceuticals Inc.